Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2006-10-27
pubmed:abstractText
Twenty-eight compounds related to dehydrozingerone (1), isoeugenol (3), and 2-hydroxychalcone (4) were synthesized and evaluated in vitro against human tumor cell replication. Except for isoeugenol analogues 27-35, most compounds exhibited moderate or strong cytotoxic activity against KB, KB-VCR (a multidrug-resistant derivative), and A549 cell lines. In particular, chalcone 15 showed significant cytotoxic activity against the A549 cell line with an IC50 value of 0.6 microg/mL. Furthermore, dehydrozingerone analogue 11 and chalcones 16 and 17 showed significant and similar cytotoxic activity against both KB (IC50 values of 2.0, 1.0, and 2.0 microg/mL, respectively) and KB-VCR (IC50 values of 1.9, 1.0, and 2.0 microg/mL, respectively) cells, suggesting that they are not substrates for the P-glycoprotein drug efflux pump.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-10381128, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-10424780, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-10648911, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-11076549, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-11170679, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-11429999, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-11730876, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-12213462, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-12408714, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-14604672, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-15210154, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-15217275, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-15363542, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-15568778, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-2359137, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-2844393, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-8267655, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-8657758, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-9219575, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-9858929, http://linkedlifedata.com/resource/pubmed/commentcorrection/17067159-9868158
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0163-3864
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1445-9
pubmed:dateRevised
2011-4-22
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents.
pubmed:affiliation
Natural Products Research Laboratories, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7360, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural